Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:06:41.233Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:06:41.233Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ec04a23f2eccb1c46d806cafb3c6508f31619b4012dc27c85b71ebd533873098
FORWARD PE RATIO
N/A
PMGC Holdings Inc.
Market Cap
$1.49M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| PMGC Holdings Inc. (ELAB) | $1.49M | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.33M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.32M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
